What Researchers Did
Researchers reported on two cases of suspected high altitude cerebral edema (HACE) in children and adolescents in the Nepal Himalayas.
What They Found
Two patients, aged 12 and 16, presented with severe symptoms like headache, vomiting, and ataxia after ascending to altitudes between 3800 m and 4500 m. The study suggests HACE can affect children and recommends adult treatment protocols, including oxygen, immediate descent, and dexamethasone. A portable hyperbaric chamber can be used for simulated descent if oxygen or actual descent is not possible.
What This Means for Canadian Patients
Canadians planning high-altitude travel with children should be aware that pediatric high altitude cerebral edema (HACE) can occur. Recognizing symptoms like severe headache, vomiting, and ataxia is crucial for prompt action. Treatment involves immediate descent and oxygen, with portable hyperbaric chambers as an option if descent is not possible.
Canadian Relevance
No direct Canadian connection identified. High altitude cerebral edema is not a Health Canada-recognized indication for hyperbaric oxygen therapy.
Study Limitations
As a case report of only two patients, these findings may not be generalizable to all children experiencing high altitude cerebral edema.